Experimental canine cancer drug could help humans, too

08/7/2013 | News-Gazette (Champaign-Urbana, Ill.), The

University of Illinois chemist Paul Hergenrother developed an anti-cancer drug, PAC-1, that has shown promise for treatment of cancer in dogs at the University of Illinois Veterinary Teaching Hospital. Veterinary oncologist and trial coordinator Tim Fan says the drug was evaluated in dogs who had advanced blood or bone cancers that had metastasized to lung tissue. The drug works by triggering cell death, and researchers plan to evaluate its use for treatment of brain cancer in humans.

View Full Article in:

News-Gazette (Champaign-Urbana, Ill.), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Attest Health Care Advisors
Nationwide, SL_Nationwide
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Wayzata, MN
Meridian Health Plan
Detroit, MI